0000000000606928

AUTHOR

Andrea Scupola

showing 1 related works from this author

PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice …

2022

Abstract Purpose PERSEUS-IT (NCT02289924) was a prospective, observational, 2-year study evaluating the effectiveness and treatment patterns of intravitreal aflibercept (IVT-AFL) in patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice in Italy. Methods Treatment-naïve patients with nAMD receiving IVT-AFL per routine clinical practice were enrolled. The primary endpoint was mean change in visual acuity (VA; decimals) from baseline to month (M) 12 and M24. Outcomes were evaluated for the overall study population and independently for the 2 treatment cohorts: regular (3 initial monthly doses, ≥ 7 injections by M12, and ≥ 4 injections between M12 and M2…

Intravitreal injectionsSettore MED/30 - Malattie Apparato VisivoRecombinant Fusion ProteinsAngiogenesis InhibitorsTreatment outcomesSensory SystemsMacular DegenerationCellular and Molecular NeuroscienceOphthalmologyReceptors Vascular Endothelial Growth FactorTreatment OutcomeRanibizumabObservational studyHumansProspective StudiesAfliberceptNeovascular age-related macular degeneration
researchProduct